NCT00969228 - Study to Evaluate Immunogenicity, Reactogenicity and Safety of Rotarix™ Vaccine in Korean Infants | Biotech Hunter

Enrollment

684

Participants

Timeline

Start Date

August 25, 2009

Primary Completion Date

July 23, 2010

Study Completion Date

July 23, 2010

Conditions

Infections, RotavirusRotavirus Vaccines

Interventions

BIOLOGICAL

Rotarix ™

Two oral doses

BIOLOGICAL

Placebo

Two oral doses

Trial Locations (18)

614-735

GSK Investigational Site, Busan

700-712

GSK Investigational Site, Daegu

701-600

GSK Investigational Site, Daegu

301-723

GSK Investigational Site, Daejeon

Unknown

GSK Investigational Site, Daejeon

GSK Investigational Site, Goyang

GSK Investigational Site, Kwangju

GSK Investigational Site, Seoul

501-717

GSK Investigational Site, Gwangju

570-711

GSK Investigational Site, Iksan

400-711

GSK Investigational Site, Incheon

561-712

GSK Investigational Site, Jeonju Jeonbuk

130-702

GSK Investigational Site, Seoul

135-710

GSK Investigational Site, Seoul

138-736

GSK Investigational Site, Seoul

139-707

GSK Investigational Site, Seoul

150-719

GSK Investigational Site, Seoul

443-721

GSK Investigational Site, Suwon, Kyonggi-do